國立高雄大學圖資館 |

Language: English

Back

Uremic toxins and organ failure

Abe, Takaaki.

Uremic toxins and organ failure

Record Type:	Electronic resources : Monograph/item
Title/Author:	Uremic toxins and organ failureedited by Hideyuki Saito, Takaaki Abe.
other author:	Saito, Hideyuki.
Published:	Singapore :Springer Singapore :2020.
Description:	viii, 180 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Uremia.
Online resource:	https://doi.org/10.1007/978-981-15-7793-2
ISBN:	9789811577932$q(electronic bk.)

Uremic toxins and organ failure
Uremic toxins and organ failure[electronic resource] /edited by Hideyuki Saito, Takaaki Abe. - Singapore :Springer Singapore :2020. - viii, 180 p. :ill. (some col.), digital ;24 cm.

1 Overview of Uremic Toxins -- 2 Review: Uremic toxins and gut microbiome -- 3 Gut microbiota and systemic uremic solute accumulation -- 4 Uremic toxin-related systemic disorders -- 5 Uremic Toxins and cardiovascular disease -- 6 Indoxyl sulfate and arteriosclerosis -- 7 Uremic Toxicity and Bone in CKD -- 8 D-serine as a novel uremic toxin -- 9 Uremic solutes and sarcopenia -- 10 Toxico-pathological role of hepatic sulfotransferase (SULT) 1A1 in acute kidney injuries -- 11 Accumulation of uremic toxins in systemic organs and the effect of AST-120.

This book describes the latest research on the gut-kidney axis of ureic solutes; the toxico-pathological mechanisms of uremic toxin-induced organ failure, including kidney and cardiovascular tissue; and the preventive therapeutic strategies for uremia and related organ failure associated with kidney injuries and diseases. Retained uremic toxins cause a variety of symptoms, such as hypertension, fatigue, renal anemia, osteoporosis and neurologic impairment, which are apparent in chronic kidney disease (CKD) patients. The human gastrointestinal tract contains trillions of microorganisms, referred to as gut microbiota, which support the host metabolism by producing nutrients, such as vitamins and short-chain fatty acids. However, they also produce various harmful uremic toxins that show renal and cardiovascular toxicity, and correlate with an increased mortality in CKD patients. The composition and balance of gut microbiota are associated with the accumulation of uremic toxins and the pathophysiology of CKD, and as such are being considered for a novel therapeutic strategy.

ISBN: 9789811577932$q(electronic bk.)

Standard No.: 10.1007/978-981-15-7793-2doiSubjects--Topical Terms:

721375
Uremia.

LC Class. No.: RC915

Dewey Class. No.: 616.635

Uremic toxins and organ failure
LDR:02605nmm a2200325 a 4500 001 589030
003 DE-He213
005 20201012134810.0
006 m d
007 cr nn 008maaau
008 210525s2020 si s 0 eng d
020 $a 9789811577932$q(electronic bk.)
020 $a 9789811577925$q(paper)
024 7 $a 10.1007/978-981-15-7793-2 $2 doi
035 $a 978-981-15-7793-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC915
072 7 $a MJR $2 bicssc
072 7 $a MED055000 $2 bisacsh
072 7 $a MJR $2 thema
082 0 4 $a 616.635 $2 23
090 $a RC915 $b .U75 2020
245 0 0 $a Uremic toxins and organ failure $h [electronic resource] / $c edited by Hideyuki Saito, Takaaki Abe.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2020.
300 $a viii, 180 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a 1 Overview of Uremic Toxins -- 2 Review: Uremic toxins and gut microbiome -- 3 Gut microbiota and systemic uremic solute accumulation -- 4 Uremic toxin-related systemic disorders -- 5 Uremic Toxins and cardiovascular disease -- 6 Indoxyl sulfate and arteriosclerosis -- 7 Uremic Toxicity and Bone in CKD -- 8 D-serine as a novel uremic toxin -- 9 Uremic solutes and sarcopenia -- 10 Toxico-pathological role of hepatic sulfotransferase (SULT) 1A1 in acute kidney injuries -- 11 Accumulation of uremic toxins in systemic organs and the effect of AST-120.
520 $a This book describes the latest research on the gut-kidney axis of ureic solutes; the toxico-pathological mechanisms of uremic toxin-induced organ failure, including kidney and cardiovascular tissue; and the preventive therapeutic strategies for uremia and related organ failure associated with kidney injuries and diseases. Retained uremic toxins cause a variety of symptoms, such as hypertension, fatigue, renal anemia, osteoporosis and neurologic impairment, which are apparent in chronic kidney disease (CKD) patients. The human gastrointestinal tract contains trillions of microorganisms, referred to as gut microbiota, which support the host metabolism by producing nutrients, such as vitamins and short-chain fatty acids. However, they also produce various harmful uremic toxins that show renal and cardiovascular toxicity, and correlate with an increased mortality in CKD patients. The composition and balance of gut microbiota are associated with the accumulation of uremic toxins and the pathophysiology of CKD, and as such are being considered for a novel therapeutic strategy.
650 0 $a Uremia. $3 721375
650 0 $a Multiple organ failure. $3 558310
650 1 4 $a Nephrology. $3 274884
650 2 4 $a Gastroenterology. $3 274091
650 2 4 $a Cardiology. $3 273804
700 1 $a Saito, Hideyuki. $3 880716
700 1 $a Abe, Takaaki. $3 880717
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-15-7793-2
950 $a Medicine (SpringerNature-11650)